Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins
3-3s represent a family of highly conserved 30 kDa acidic proteins. 14-3-3s recognize and
bind specific phospho-sequences on client partners and operate as molecular hubs to …
bind specific phospho-sequences on client partners and operate as molecular hubs to …
LRRK2 and α-synuclein: distinct or synergistic players in Parkinson's disease?
Parkinson's disease (PD) is the most common neurodegenerative movement disorder,
characterized by prominent degeneration of dopaminergic neurons in the substantia nigra …
characterized by prominent degeneration of dopaminergic neurons in the substantia nigra …
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease
M Kedariti, E Frattini, P Baden, S Cogo… - npj Parkinson's …, 2022 - nature.com
Leucine-rich repeat kinase 2 (LRRK2) is a kinase involved in different cellular functions,
including autophagy, endolysosomal pathways, and immune function. Mutations in LRRK2 …
including autophagy, endolysosomal pathways, and immune function. Mutations in LRRK2 …
The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
SH Schmidt, MJ Knape, D Boassa… - Proceedings of the …, 2019 - National Acad Sciences
Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein, and LRRK2 mutants
are recognized risk factors for Parkinson's disease (PD). Although the precise mechanisms …
are recognized risk factors for Parkinson's disease (PD). Although the precise mechanisms …
14-3-3 proteins: novel pharmacological targets in neurodegenerative diseases
FS Pair, TA Yacoubian - Trends in pharmacological sciences, 2021 - cell.com
14-3-3 proteins are a family of proteins expressed throughout the body and implicated in
many diseases, from cancer to neurodegenerative disorders. While these proteins do not …
many diseases, from cancer to neurodegenerative disorders. While these proteins do not …
LRRK2 phosphorylation, more than an epiphenomenon
A Marchand, M Drouyer, A Sarchione… - Frontiers in …, 2020 - frontiersin.org
Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are linked to autosomal
dominant Parkinson's disease (PD), and genetic variations at the LRRK2 locus are …
dominant Parkinson's disease (PD), and genetic variations at the LRRK2 locus are …
Divergent effects of G2019S and R1441C LRRK2 mutations on LRRK2 and Rab10 phosphorylations in mouse tissues
L Iannotta, A Biosa, JH Kluss, G Tombesi… - Cells, 2020 - mdpi.com
Mutations in LRRK2 cause familial Parkinson's disease and common variants increase
disease risk. LRRK2 kinase activity and cellular localization are tightly regulated by …
disease risk. LRRK2 kinase activity and cellular localization are tightly regulated by …
Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2
SH Schmidt, JH Weng, PC Aoto… - Proceedings of the …, 2021 - National Acad Sciences
To explore how pathogenic mutations of the multidomain leucine-rich repeat kinase 2
(LRRK2) hijack its finely tuned activation process and drive Parkinson's disease (PD), we …
(LRRK2) hijack its finely tuned activation process and drive Parkinson's disease (PD), we …
Binding of the human 14-3-3 isoforms to distinct sites in the leucine-rich repeat kinase 2
JT Manschwetus, M Wallbott, A Fachinger… - Frontiers in …, 2020 - frontiersin.org
Proteins of the 14-3-3 family are well known modulators of the leucine-rich repeat kinase 2
(LRRK2) regulating kinase activity, cellular localization, and ubiquitylation. Although binding …
(LRRK2) regulating kinase activity, cellular localization, and ubiquitylation. Although binding …
The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
N Cresto, C Gardier, F Gubinelli… - European Journal of …, 2019 - Wiley Online Library
Our understanding of the mechanisms underlying Parkinson's disease, the once
archetypical nongenetic neurogenerative disorder, has dramatically increased with the …
archetypical nongenetic neurogenerative disorder, has dramatically increased with the …